Cipla Ltd Share Price – NSE  / BSE

Pharmaceuticals, Mid Cap

Cipla has allotted 44,770 equity shares under ESOS on 04 June 2026. Consequently, the paid up equity share capital has increased to Rs 1,61,56,90,632 comprising of 80,78,45,316 equity shares of face value Rs 2 each.

Cipla has allotted 17,915 equity shares under ESOS on 14 May 2026. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 1,61,56,01,092 comprising of 80,78,00,546 equity shares of face value Rs 2 each.

Cipla announced that the 90th Annual General Meeting(AGM) of the company will be held on 25 June 2026.

Net profit of Cipla declined 54.61% to Rs 554.64 crore in the quarter ended March 2026 as against Rs 1221.84 crore during the previous quarter ended March 2025. Sales declined 2.02% to Rs 6464.26 crore in the quarter ended March 2026 as against Rs 6597.72 crore during the previous quarter ended March 2025.

For the full year,net profit declined 26.43% to Rs 3879.23 crore in the year ended March 2026 as against Rs 5272.52 crore during the previous year ended March 2025. Sales rose 2.09% to Rs 27711.69 crore in the year ended March 2026 as against Rs 27145.40 crore during the previous year ended March 2025.

Powered by Capital Market - Live News